Showing results (1621-1630 of 2,046) with videos related to
Sort By:
Pageof 205
Circulation. Cardiovascular Imaging|March 26, 2021
Implementation of a Myocardial Perfusion Imaging Risk Algorithm to Inform Appropriate Downstream Invasive Testing and TreatmentAnirudh Kumar, Divyang R Patel, Serge C Harb, et al.European Heart Journal Open|August 3, 2022
Autoimmune connective tissue diseases and aortic valve replacement outcomes: a population-based studyMohamed M Gad, Devora Lichtman, Anas M Saad, et al.Cardiovascular Diagnosis and Therapy|July 23, 2021
Outcomes of contemporary imaging-guided management of sinus of Valsalva aneurysmsBo Xu, Duygu Kocyigit, Carlos Godoy-Rivas, et al.Journal of Cardiovascular Electrophysiology|January 25, 2018
Troubleshooting electromagnetic interference in a patient with centrifugal flow left ventricular assist device and subcutaneous implantable cardioverter defibrillatorAsim S Ahmed, Parin J Patel, Shiv Bagga, et al.Theranostics|February 7, 2024
The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapyYing Zhang, Venu Akhil, Ho Seong Seo, et al.Journal of Lipid Research|November 22, 2021
Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammationPallavi Mukherjee, Arnab Chattopadhyay, Victor Grijalva, et al.The American Journal of Cardiology|October 30, 2016
Prognostic Significance of Ischemic Mitral Regurgitation on Outcomes in Acute ST-Elevation Myocardial Infarction Managed by Primary Percutaneous Coronary InterventionAmgad Mentias, Mohammad Q Raza, Amr F Barakat, et al.Molecular Cancer Therapeutics|April 17, 2014
Geranylgeranylacetone blocks doxorubicin-induced cardiac toxicity and reduces cancer cell growth and invasion through RHO pathway inhibitionPolina Sysa-Shah, Yi Xu, Xin Guo, et al.American Heart Journal|June 25, 2005
Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?Vladimir Dzavik, Lynn A Sleeper, Michael H Picard, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 17, 2006
Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosisKristin E Larsen, Yvonne Schmitz, Matthew D Troyer, et al.Pageof 205